Nvidia Eyes Return to China Market After $8 Billion Setback Nvidia is preparing to re-enter the Chinese market with its H20 chip, a move that could recover billions in lost revenue after facing strict U.S. export restrictions. In a blog post released late Monday, Nvidia said it is seeking approval to resume sales of its H20 chip—a lower-spec version of its Hopper series tailored to comply with U.S. trade rules. The company disclosed it has received assurances from the U.S. government that licenses for the chip “will be granted,” opening the door for a return to the market. This development comes just three months after Nvidia warned that tighter U.S. regulations would significantly impact its business in China. In April, the company took a $4.5 billion charge in its fiscal first quarter, largely due to excess inventory and canceled orders related to the H20 chip. It estimated $2.5 billion in lost revenue for that quarter alone and forecast an additional $8 billion shortfall in the current quarter. The turnaround follows a series of high-level meetings between U.S. and Chinese officials earlier this month. While the U.S. Commerce Department has not commented, Nvidia is optimistic it can resume shipments soon. The potential return to China comes as Nvidia bets big on artificial intelligence. CEO Jensen Huang said in a May interview that the global AI market could grow to $50 billion within a few years—a market China plays a critical role in. If H20 sales resume, it could mark a major win for Nvidia’s efforts to navigate geopolitical headwinds without missing out on the AI boom.

Big Tech Gets a Boost From New Tax Law as Markets Shrug Off Tariff Jitter Investors may be uneasy over the latest tariff headlines, but history suggests that fear might be misplaced — especially with the S&P 500 sitting just 0.3% off all-time highs. According to UBS, when the index is at record levels, it typically takes 105 days before a 5% pullback occurs. In that time, equities tend to outperform cash and short-term Treasurys. So while going defensive might feel safe, historically it hasn’t been the winning strategy. Mike Wilson, Morgan Stanley’s chief U.S. equity strategist, sees additional reasons for investor confidence. One is the belief that many of the proposed tariffs — particularly on Mexico and Canada — won’t be fully implemented. Goods that meet the rules under the U.S.-Mexico-Canada Agreement (USMCA), such as those manufactured entirely within member countries or significantly transformed, are likely to be exempt. Wilson’s team analyzed which industries are most exposed to tariffs. U.S. goods-focused sectors rely heavily on imports from China, followed by Mexico, Canada, and the EU. The real risk, they argue, would be a steep escalation in China tariffs — both due to broad sector exposure and the high market cap concentration of affected companies. Tariffs on Mexico would be the next-biggest threat, particularly if USMCA exemptions fall through. A specific area of concern is semiconductors. New levies on chips — vital to U.S. supply chains — could have broad ripple effects. “This could become a major issue depending on how Section 232 tariffs are applied,” the strategists warned. But there’s another story playing out beneath the surface — a rapid turnaround in earnings expectations. Analyst revisions have flipped from -25% in April to +3% now. Financials, in particular, have seen the strongest rebound in expected earnings per share. Then there’s the impact of the newly passed tax legislation, nicknamed the “One Big Beautiful Bill.” A key provision allows companies to expense R&D costs upfront, effectively lowering the corporate tax rate from 20% to around 13%. While this change won’t affect GAAP earnings — which already require immediate expensing — it will significantly improve cash flow. That cash flow benefit could explain why the so-called “Magnificent Seven” tech titans have led the market in recent months. Companies with more than $10 billion in deferred R&D tax assets — and thus poised to gain the most — include Alphabet, Amazon, Meta, Microsoft, Apple, Intel, and General Motors, according to separate investment bank research.

HSBC: Market Earnings Forecasts Are Too Pessimistic Ahead of Q2 Season With second-quarter earnings season about to begin, HSBC says the market is underestimating corporate performance — setting the stage for positive surprises. Despite recent shifts in U.S. trade policy, HSBC strategists, led by chief multi-asset strategist Max Kettner, believe markets are no longer as reactive to tariff headlines. “The tariff debate has faded into the background following the U.S.-China trade pause,” they note. “Risk assets are showing less sensitivity to these developments.” They point out that the U.S. economy remains solid, especially with consumer spending rebounding. As a result, current consensus earnings forecasts may be too low. “Pessimistic estimates create room for upside surprises, which could lead to positive earnings revisions and support further gains in risk assets,” the strategists explain. While tariffs carry inflation risks, HSBC says there’s little evidence of that so far — in fact, inflation appears to be cooling. Tariffs may also serve to keep investor positioning in check. Looking ahead to Q2 results, HSBC challenges the market’s expectation for a quarter-on-quarter earnings decline. “We don’t agree,” the team states. “Earnings estimates have seen the largest cuts in three years, and the front-loading of economic activity should provide a temporary boost to Q2 EPS.” Concerns about market valuation are also overstated, according to HSBC. On an equal-weighted basis, the S&P 500 is only slightly above its historical average — far from overvalued, in their view. In fact, many widely held bearish views on the U.S. — from slowing growth to a weaker dollar and continued equity underperformance — could be misguided. HSBC sees these as “pain trades” likely to catch investors off guard. Reflecting its bullish stance, HSBC raised its U.S. equity allocation by 4 percentage points, now recommending a 31% weight in its multi-asset portfolio. The full portfolio allocation is: 50% equities, 25% government bonds, 10% corporate credit, 5% commodities, and 5% cash.